Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results ...
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results ...
Source: pr-inside.com
Page 4 - Mark Oki News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Oki. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Oki Today - Breaking & Trending Today
Aytu BioPharma, Inc.: Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
Abhinav Jain of Nantahala Capital Management, LLC Joins the Company's Board of Directors Upon ClosingPotential for Additional $7 Million in Event of Exercise of Common Warrants in FullExtends Interest
Source: finanznachrichten.de
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to the Aytu BioPharma Fiscal 2023 Q3 Results Conference Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Aytu BioPharma, Inc.: Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription
Source: finanznachrichten.de
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results ...
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results ...
Source: pr-inside.com